Bringing Regenerative Medicine to a Rare Bone Condition in Children

Denis Dufrane, co-founder and CEO of Novadip, discusses the rare pediatric bone disorder congenital pseudarthrosis of the tibia, the company’s cell therapy to address the condition, and how it works.